mTrio® is designed to both improve test compliance and reduce the rate of user error complications of diabetes that is attributed to being the single largest component of healthcare cost for the disease.

Pepex® exceeds the objectives of a rapidly growing diabetic population and ever demanding requirements of healthcare providers with the improved accuracy of its proprietary CCM® sensors modules, on a HIPAA compliant secure network, using wireless technology and the integration of cloud based predictive analytics. These features are provided through a tiered monthly subscription service that automates all of the provisioning, record keeping and performance analysis for the diabetic customer.

Verizon’s recently FDA approved Converged Health Management Solution platform is ideal for mTrio® providing clinicians with access to up-to-date patient data from connected biometric devices so they can more efficiently monitor and manage patients at their home, or when they are on the go.